AperçuGraphiqueActualitésTraderScreen

HSBC Knock-Out CHKP/  DE000HS6T8E9  /

EUWAX
08/11/2024  08:49:01 Chg.+0.26 Bid22:00:36 Demandez à22:00:36 Sous-jacent Prix d'exercice Date d'expiration Type d'option
2.14EUR +13.83% -
Bid taille: -		 -
Ask la taille: -		 Check Point Software... 155.334 USD 31/12/2078 Call
TeleTrader 00:26 California man arrested for trespassing at Mar-a-Lago
Newsfile Corp 22/10 SEC Charges Four Companies With Misleading Cyber Disclosures
Newsfile Corp 20/10 T-NanoBio Therapeutics, Inc. to Present at the LD Micro Main Event XVII
TeleTrader 14/10 US Secret Service: Trump not in danger during latest incident
TeleTrader 13/10 Armed man using false passes arrested near Trump's California rally
TeleTrader 10/09 Israeli army stops UN convoy for 8 hours, UNRWA says
GlobeNewswire 03/09 Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and E...
GlobeNewswire 30/08 Carahsoft Sponsors 15th Annual Billington Cybersecurity Summit in Washington, D.C. on September 3-6...
GlobeNewswire 29/08 Anaptys Announces Participation in September Investor Conferences
GlobeNewswire 28/08 Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Pro...
GlobeNewswire 28/08 BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 27/08 Check Point Software to Acquire Cyberint to Transform Security Operations and Expand Managed Threat ...
TeleTrader 27/08 Ukrainian troops allegedly trying to enter Russia near Belgorod
GlobeNewswire 14/08 Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 14/08 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13/08 Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 13/08 Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
GlobeNewswire 13/08 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire 13/08 Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 12/08 Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...
GlobeNewswire 12/08 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
GlobeNewswire 12/08 Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire 08/08 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08/08 Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire 08/08 PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting